Antiplasmodial Activity Evaluation of a Bestatin-Related Aminopeptidase Inhibitor, Phebestin-Reference-Cited by-全球学者库

Antiplasmodial Activity Evaluation of a Bestatin-Related Aminopeptidase Inhibitor, Phebestin

Published:2023-07-18 Issue:7 Volume:67 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Ariefta Nanang R.¹^ORCID,Pagmadulam Baldorj¹²,Hatano Masaki³,Ikeda Noriko³,Isshiki Kunio³,Matoba Kazuaki³,Igarashi Masayuki³,Nihei Coh-ichi³,Nishikawa Yoshifumi¹^ORCID

Affiliation:

1. National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Inada-cho, Obihiro, Japan

2. Laboratory of Microbial Synthesis, Institute of General and Experimental Biology, Mongolian Academy of Sciences, Ulaanbaatar, Mongolia

3. Institute of Microbial Chemistry (BIKAKEN), Tokyo, Japan

Abstract

The increasing burden and spread of resistant malaria parasites remains an immense burden to public health. These factors have driven the demand to search for a new therapeutic agent.

Funder

MEXT | Japan Society for the Promotion of Science

帯広畜産大学 | National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/aac.01606-22

Reference43 articles.

1. World Trade Report 2021

2. That Was Then But This Is Now: Malaria Research in the Time of an Eradication Agenda

3. The role of anti-malarial drugs in eliminating malaria

4. History, Dynamics, and Public Health Importance of Malaria Parasite Resistance

5. The Aminopeptidase Inhibitor CHR-2863 Is an Orally Bioavailable Inhibitor of Murine Malaria